Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upConference
10th IP Forefront Pharma Forum 10th IP Forefront Pharma Forum
September 17-19, 2025
Shanghai
Conference
9th IP Forefront Pharma Forum 2024 9th IP Forefront Pharma Forum 2024
October 16-18, 2024
Suzhou
Books
Biosimilars Litigation and Client Counseling Biosimilars Litigation and Client Counseling
June 17, 2024
American Bar AssociationConference
2024 @Philly Cell and Gene Therapy Annual Conference 2024 @Philly Cell and Gene Therapy Annual Conference
June 14-15, 2024
Philadelphia
Articles
Trending at the PTAB: Real Party in Interest and IPR Trending at the PTAB: Real Party in Interest and IPR
May 31, 2024
Law360Webinar
Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval
November 28, 2023
Webinar
Webinar
Secondary Patents on Both Sides of the Pond: Impact of Clinical Trials on Patentability Secondary Patents on Both Sides of the Pond: Impact of Clinical Trials on Patentability
November 2, 2023
Webinar
Webinar
Patent Drafting for Multiple Jurisdictions Patent Drafting for Multiple Jurisdictions
October 11, 2023
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.